fda d.i.s.c.o. burst edition: fda approval of sarclisa (isatuximab-irfc) in combination with carf...
Published 2 months ago • 25 plays • Length 3:30Download video MP4
Download video MP3
Similar videos
-
3:07
what does the fda approval of sarclisa® (isatuximab) mean for myeloma patients?
-
0:51
how much it cost to make an appointment with fda?
-
2:41
ifr co-registration and virtual angioplasty
-
4:14
static and dynamic performance characterization of 3.3kv 30a discrete sic mosfets
-
8:25
proper saddle fit with doc jenni grimmett dvm, part 2
-
0:53
consensus standards webinar for the fda estar (mar 14)
-
32:09
fda aligns qmsr with iso 13485?
-
3:49
shimadzu fluorospeed x1 edition patient-side r/f system
-
21:42
what is an fda prestar?
-
41:22
first fda-authorized use of crispr diagnostics for covid-19…next up: stopcovid!
-
6:53
ssid matching tool - module-d - wrapup
-
0:30
fda qsr compliance for medical device manufacturers | fda consultant | gmp
-
56:39
centers of excellence at the fda: a disease-oriented approach to medical product development
-
4:55
case review: ifr co-registration in 3 vessel disease with dr. arnold seto
-
1:59
case review: ifr co-registration in diffuse lad leading to omt with dr. sayan sen
-
58:41
update on diagnosis and therapy of plasma cell dyscrasias
-
1:18
aecq sic fet’s | datasheet preview
-
12:11
covid-19 lab-developed tests: the fda's evolving approach
-
15:06
heavy armored divisions - fda and ce approved platforms
-
4:52
sarah talks about fuchs' dystrophy & dmek by dr. matthew feng | price vision group
-
0:45
introducing our new fda class i medical devices